Moleculin Biotech, Inc.
Income Statement
| Line Item | FY2017 | FY2016 |
|---|---|---|
| Revenue | $0 | $0 |
| Cost of Revenue | — | — |
| Gross Profit | — | — |
| Gross Margin | — | — |
| Operating Expenses | ||
| Research & Development | $4.5M | $1.5M |
| SG&A Expense | $4.1M | $2.4M |
| Operating Income | $-8.7M | $-3.9M |
| Operating Margin | — | — |
| Interest Expense | $0 | $43.0K |
| Pretax Income | — | — |
| Income Tax Expense | $0 | $0 |
| Net Income | $-9.8M | $-3.9M |
| Net Margin | — | — |
| EPS (Basic) | $-0.06 | $-0.04 |
| EPS (Diluted) | $-0.06 | $-0.04 |
| Shares Outstanding (Basic) | 193.2M | 109.5M |
| Shares Outstanding (Diluted) | 193.2M | 109.5M |
| Dividends Per Share | — | — |